CYRX: Cryoport, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 311.44
Enterprise Value ($M) 499.90
Book Value ($M) 401.90
Book Value / Share 8.05
Price / Book 0.77
NCAV ($M) 39.98
NCAV / Share 0.80
Price / NCAV 7.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.18
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.23

Liquidity (mrq)
Quick Ratio 4.94
Current Ratio 5.29

Balance Sheet (mrq) ($M)
Current Assets 341.57
Assets 703.49
Liabilities 301.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 228.38
Operating Income -67.06
Net Income -114.76
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.32
Cash from Investing 176.81
Cash from Financing -161.53

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Alger Associates Inc 5.20 -4.88
02-14 13G/A Brown Capital Management Llc 9.02 -13.45
02-13 13G/A Cadian Capital Management, Lp 9.97 14.10
11-12 13G/A Vanguard Group Inc 5.74 0.00
10-16 13G/A Integrated Core Strategies (us) Llc 7.50 32.42

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 22,249 250,106 8.90
2025-03-13 57,485 372,570 15.43
2025-03-12 107,640 1,025,953 10.49
2025-03-11 160,820 1,415,235 11.36
2025-03-10 102,252 1,352,089 7.56

(click for more detail)

Similar Companies
CVKD – Cadrenal Therapeutics, Inc. CYCC – Cyclacel Pharmaceuticals, Inc.
CYCN – Cyclerion Therapeutics, Inc. CYTH – Cyclo Therapeutics, Inc.
DARE – Daré Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io